Status:
TERMINATED
Safety and Efficacy Study of Prosaptide to Treat Neuropathic Pain in HIV-Positive Patients
Lead Sponsor:
Savient Pharmaceuticals
Collaborating Sponsors:
Neurologic AIDS Research Consortium (NARC)
Conditions:
HIV
Peripheral Nervous System Disorders
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
This is a double-blind, placebo-controlled, parallel groups study to determine whether prosptide is effective in relieving pain in patients who have sensory neuropathic pain related to their HIV infec...
Detailed Description
Sensory neruopathies are the most frequent neurological complicaton of HIV infection and its treatmet with antiretrovirals. To date, there are few effective treatments, and all are symptomatic treatme...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Ages 18 years and older
Exclusion
Key Trial Info
Start Date :
September 1 2003
Trial Type :
INTERVENTIONAL
End Date :
December 1 2004
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT00286377
Start Date
September 1 2003
End Date
December 1 2004
Last Update
February 3 2006
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.